“Sec Pharma, founded in 2000, has consistently delivered, met and exceeded the industry needs making us one of the largest European pharmaceutical recruitment specialists.
Our professional work ethic is underpinned by our dedicated Account Management team and Internal Training and Development.
Due to our in depth qualification process both on active and passive candidates, we have further established our long standing relationship with several leading Pharmaceutical Companies.
The world’s premiere CRO has also commissioned SEC to carry out an unrivalled market analysis and salary survey based on our industry knowledge and multicultural team of specialists.”
This presentation covers the capabilities of a European talent acquisition and recruitment specialist firm. It discusses the firm's client list, geographical coverage, sector expertise, recruitment process, account management, and specific services. It also provides testimonials and highlights the firm's specialist areas including clinical, medical, pharmaceutical, engineering, technology, and analytics skills. The presentation is intended to provide an overview of the firm's offerings and capabilities in recruiting talent across multiple industries and countries in Europe.
The annual report summarizes SGS's financial results for 2014. Some key points:
- Revenue grew 5.4% to CHF 5.9 billion, with 4% organic growth and additional growth from acquisitions.
- Adjusted operating income was CHF 947 million, a 2.6% increase excluding currency effects.
- Net profit reached CHF 629 million, an 11.1% increase excluding currency effects.
- Cash flow from operations was CHF 912 million, used to fund investments and dividend payments.
- 10 acquisitions were completed adding CHF 36 million in revenue and CHF 7 million to operating income.
SGS is the world's leading inspection, verification, testing and certification company, operating a network of over 1,650 offices and laboratories worldwide. In 2013, SGS acquired 12 businesses across 10 countries, further expanding its service portfolio. The annual report provides an overview of SGS's financial highlights and business review for 2013, including revenue and adjusted operating income by business and region. SGS achieved organic revenue growth of 4.4% and total revenue of CHF 5.8 billion for the year.
SGS spans the globe and this report highlights the openness and willingness between our geographies to share information and turn regional challenges into global opportunities.
Successfully navigating the challenges of today’s rapidly globalising marketplace led us to once again redefine the line between service partner, technological innovator and solution provider. I pushed each of our 10 operational regions, comprising a multitude of countries, industries and businesses, to seek out and deliver an impressive array of new services in 2013. The vision has helped SGS remain at the forefront of developing cross-industry synergies: unique offerings that ease the increasing pressures on businesses.
Throughout the year our 80,000 employees and 1,650 offices and laboratories around the world continued to exceed the expectations of our customers, and kept SGS known as the industry ‘best in class’.
Read on and discover for yourself the imagination, drive and determination of SGS and how we remained as the world’s leading inspection, verification, testing and certification company during 2013.
- Christopher Kirk, CEO
SGS is a leading inspection, verification, testing and certification company established in 1878. It aims to be the most competitive and productive service organization in the world with core competencies in inspection, verification, testing and certification. SGS has over 80,000 employees operating over 1,650 offices and laboratories worldwide. It provides services across various industries including agriculture, automotive, aviation, construction, chemicals, consumer goods, energy, finance, industrial manufacturing, life sciences, logistics, mining, oil and gas, public sector. In 2014, SGS reported total revenue of CHF 5.9 billion, net profit of CHF 629 million, and proposed a dividend of CHF 68 per share.
Life Science Co. focuses on developing innovative technologies to address large unmet clinical needs. It has a strong intellectual property portfolio and management team with relevant experience. The company's technology has barriers to entry and differentiation compared to standard of care. It is developing products targeting a large addressable market, with the potential to capture a significant percentage of the market over time. The company projections show potential for high growth and profitability. However, risks include challenges demonstrating reimbursement and achieving early traction.
Novartis has 10 strategic objectives across 4 perspectives: financial, customer, internal process, and innovation/learning. 29 KPIs were identified to measure performance. The objectives focus on improving shareholder value, asset utilization, product quality and distribution, production processes, innovation, and international expansion. Key KPIs include return on equity, customer satisfaction, production cycle time, research and development investment, and foreign market share.
This presentation covers the capabilities of a European talent acquisition and recruitment specialist firm. It discusses the firm's client list, geographical coverage, sector expertise, recruitment process, account management, and specific services. It also provides testimonials and highlights the firm's specialist areas including clinical, medical, pharmaceutical, engineering, technology, and analytics skills. The presentation is intended to provide an overview of the firm's offerings and capabilities in recruiting talent across multiple industries and countries in Europe.
The annual report summarizes SGS's financial results for 2014. Some key points:
- Revenue grew 5.4% to CHF 5.9 billion, with 4% organic growth and additional growth from acquisitions.
- Adjusted operating income was CHF 947 million, a 2.6% increase excluding currency effects.
- Net profit reached CHF 629 million, an 11.1% increase excluding currency effects.
- Cash flow from operations was CHF 912 million, used to fund investments and dividend payments.
- 10 acquisitions were completed adding CHF 36 million in revenue and CHF 7 million to operating income.
SGS is the world's leading inspection, verification, testing and certification company, operating a network of over 1,650 offices and laboratories worldwide. In 2013, SGS acquired 12 businesses across 10 countries, further expanding its service portfolio. The annual report provides an overview of SGS's financial highlights and business review for 2013, including revenue and adjusted operating income by business and region. SGS achieved organic revenue growth of 4.4% and total revenue of CHF 5.8 billion for the year.
SGS spans the globe and this report highlights the openness and willingness between our geographies to share information and turn regional challenges into global opportunities.
Successfully navigating the challenges of today’s rapidly globalising marketplace led us to once again redefine the line between service partner, technological innovator and solution provider. I pushed each of our 10 operational regions, comprising a multitude of countries, industries and businesses, to seek out and deliver an impressive array of new services in 2013. The vision has helped SGS remain at the forefront of developing cross-industry synergies: unique offerings that ease the increasing pressures on businesses.
Throughout the year our 80,000 employees and 1,650 offices and laboratories around the world continued to exceed the expectations of our customers, and kept SGS known as the industry ‘best in class’.
Read on and discover for yourself the imagination, drive and determination of SGS and how we remained as the world’s leading inspection, verification, testing and certification company during 2013.
- Christopher Kirk, CEO
SGS is a leading inspection, verification, testing and certification company established in 1878. It aims to be the most competitive and productive service organization in the world with core competencies in inspection, verification, testing and certification. SGS has over 80,000 employees operating over 1,650 offices and laboratories worldwide. It provides services across various industries including agriculture, automotive, aviation, construction, chemicals, consumer goods, energy, finance, industrial manufacturing, life sciences, logistics, mining, oil and gas, public sector. In 2014, SGS reported total revenue of CHF 5.9 billion, net profit of CHF 629 million, and proposed a dividend of CHF 68 per share.
Life Science Co. focuses on developing innovative technologies to address large unmet clinical needs. It has a strong intellectual property portfolio and management team with relevant experience. The company's technology has barriers to entry and differentiation compared to standard of care. It is developing products targeting a large addressable market, with the potential to capture a significant percentage of the market over time. The company projections show potential for high growth and profitability. However, risks include challenges demonstrating reimbursement and achieving early traction.
Novartis has 10 strategic objectives across 4 perspectives: financial, customer, internal process, and innovation/learning. 29 KPIs were identified to measure performance. The objectives focus on improving shareholder value, asset utilization, product quality and distribution, production processes, innovation, and international expansion. Key KPIs include return on equity, customer satisfaction, production cycle time, research and development investment, and foreign market share.
What we do: Pharmaceutical Consulting, Strategic Consulting, Pharmaceutical Strategic Consulting
Strategic Opportunity Assessment – Diagnostic process for continuously improving project managements performances.
Clinical site; KOL Evaluation in Asia – Development of clinical sites and evaluation of KOL treatment algorithms
Compliant manufacturing Site Proposal – Forecasting optimal asset allocation to achieve compliant manufacturing.
The new role of R&D and process for new products in pharmaceutical industry has been established
Productivity increase of Orion R&D within 6 years by :
-Classification of partners
-Partnering and outsourcing models in use
Need of reliable key metrics to value R&D investment and boost the future growth of the company
Gary Noy, Director of Integrated FM at Pfizer - Facilities management service...Global Business Events
This document summarizes Pfizer's facilities management outsourcing in Europe, the Middle East, and Africa (EMEA). It provides background on Pfizer's global operations and EMEA real estate footprint. In 2008-2009, Pfizer outsourced many FM services across EMEA to a single vendor, CBRE, through a competitive bidding process. Lessons learned from that initial outsourcing included allowing more time for change management and establishing clear contract governance. The current approach involves another desk-top outsourcing review starting in 2012 to select a new vendor for EMEA FM services beginning in 2014.
Este documento proporciona una introducción al concepto de outsourcing y sus características. Explica que el outsourcing implica delegar responsabilidades no esenciales a un proveedor externo para reducir costos y aumentar la eficiencia. También analiza las ventajas e inconvenientes del outsourcing, los tipos de contratos utilizados, y cómo este enfoque apoya la toma de decisiones gerenciales.
This document discusses outsourcing in the pharmaceutical industry. It defines outsourcing as transferring portions of work to outside suppliers in order to reduce costs. The main types of outsourcing in pharma include research and development, clinical trials, manufacturing, packaging, and sales/marketing. The key drivers of outsourcing are focusing on core strengths, reducing costs, and decreasing time to market. While outsourcing provides advantages like cost reductions, it also presents risks such as loss of managerial control and internal talent. Overall, outsourcing allows pharma companies to exploit new drug technologies while solving problems, though successful management of vendor relationships is critical.
Pfizer office of the future case study Mohamed Zaid
This document discusses Pfizer's Office of the Future (OOF) program. It provides an overview of Pfizer as a company and describes the OOF program, which involves outsourcing routine office work to companies in India. This allows Pfizer employees to focus on more strategic work instead of tasks like document creation and research. The program was implemented by establishing departments in outsourcing companies responsible for different tasks. It helps Pfizer improve efficiency by reducing costs and time spent on projects. However, the approach may not be suitable for all organization types and presents some risks if communication or systems fail.
Strategies and Opportunities of Outsourcing -Product Development and Manufact...daisyrmuzzio
This document discusses strategies and opportunities for outsourcing pharmaceutical product development and manufacturing services from Latin America. It notes that Latin America has the potential to become a key global outsourcing hub for these activities in the next 5-10 years due to benefits like industry growth, innovation, and capabilities to address local health needs. It highlights several Latin American countries' strengths in areas like clinical research capabilities, manufacturing infrastructure, and a growing biotech industry. It also discusses expectations for the region to close gaps in areas like regulatory environments and intellectual property protections.
The document is a business plan for BioCare Ltd's product called SlickStick. It contains details about the product, which is a rapid diagnostic test kit for malaria that combines a dipstick with a smartphone app for automated analysis. The business plan includes sections on the company description, product details, market analysis, financial projections, and risk analysis. It presents data showing the large market opportunity for lower-cost malaria diagnostics, especially in developing countries.
The document discusses the pharmaceutical industry and Pfizer's position as one of the largest companies in the sector, facing challenges from increasing competition, shorter patents, and the need to diversify beyond blockbuster drugs. It analyzes Pfizer's strengths in areas like research and development as well as opportunities for the company to move into new areas like medical devices, health insurance, and genetically modified foods.
The document discusses the history and evolution of outsourcing in various industries from the 1980s to present day. It covers the reasons companies outsource functions like production, purchasing, logistics, and services to reduce costs and risks. The document also outlines advantages and disadvantages of outsourcing as well as best practices for effective outsourcing.
The document summarizes research into marketing practices of pharmaceutical companies through case studies and interviews. Case studies of Claritin and Lipitor found differences in packaging and advertising between US/Canada and Europe. Interviews found that pharmaceutical representatives meet with doctors and pharmacists for 10-30 minutes to provide information, but independent assessment is still needed. While representatives have useful roles, direct-to-consumer drug advertising is seen as generally inappropriate.
Doug Kessler - Avoiding Crap - Succeeding at Content Marketing smm13Our Social Times
The document discusses strategies for creating "home run" content that performs significantly better than other content. It argues that home run content earns disproportionate attention, improves the performance of all other content, and can overcome obstacles like search engine inertia. It provides eight tips for producing home run content, such as swinging for the fences, studying other successful home runs, shamelessly stealing ideas from far-reaching sources, targeting psychographics, tapping into emotion, and addressing timely issues with empathy and confidence. The overall goal is to aim high and steal ideas freely in order to create content that can act as a home run.
Multi Format Content Strategy: Making Your Assets Go As Far As PossibleJames Carson
The document discusses elements of a content strategy, including creating different types of content assets for distribution across various platforms. It emphasizes starting with a user journey and having a central idea or theme. Different content formats are described as well as owned, earned and paid platforms. The overall message is that an effective content strategy focuses on the user and brings together various elements like formats, platforms and storytelling around a core idea.
How to Develop a PowerPoint Pitch Deck for Biotech Investor PresentationsCraig Shimasaki
A critical tool for all biotech entrepreneurs is an Investor Slide Deck or “Pitch” Deck. This example is provided to help those who want guidance on what topics and information are important for a biotech investor presentation. I have put together some basic information about what a biotech investor pitch deck should contain when presenting for the first time to a group of potential investors. Realize that this is not a template per se in which to simply fill in the blanks, but an ordered list of topics that are significant to most all biotechnology investors. For more information read the BioBlog at www.biosourceconsulting.com
Outsourcing es el proceso de contratar una empresa externa para realizar tareas específicas de una compañía. Esto puede reducir costos al evitar mantener un departamento interno. Algunas ventajas incluyen menores gastos, acceso a especialización externa y poder enfocarse en el negocio principal. Los contratos de outsourcing típicamente duran entre 3 a 10 años y cubren áreas como recursos humanos, TI, manufactura u otros procesos.
The document discusses outsourcing and provides examples of common business functions that are outsourced such as IT services, email hosting, database management, and network support. It notes that companies outsource to reduce costs, access new technologies, and focus on core competencies. The benefits and potential problems of outsourcing are also summarized.
El documento proporciona una introducción al concepto de outsourcing, explicando que es una estrategia en la que una empresa delega ciertas actividades a empresas especializadas externas para reducir costos y mejorar la eficiencia. Luego, describe algunos pioneros y ejemplos comunes de outsourcing, así como consideraciones clave para implementarlo de manera exitosa, como seleccionar el proveedor adecuado y gestionar efectivamente la transición.
Here are some key points to consider when managing a pharmaceutical product portfolio across the product life cycle:
- Balance pipeline, in-line, and mature products to ensure continuous revenue and profit streams as products move through stages of the PLC
- Allocate R&D, marketing resources appropriately based on products' stage in PLC
- Consider portfolio synergies - how products complement each other's markets, sales forces, etc.
- Manage patent expirations and generic competition for in-line products
- Continuously evaluate portfolio for gaps, underperformers, and divestment/acquisition opportunities
- Ensure pipeline has mix of early/late stage products and therapeutic areas for future growth
The goal is a balanced,
50 Stats You Need to Know About Content Marketing NewsCred
The 50 most important content marketing statistics that will help you prove the value of content and keep you accountable. To see a full list of the sources please click here: http://blog.newscred.com/article/4d5125444fcd2d72ebd17b282107d742/50-stats-you-need-to-know-about-content-marketing
Invida is a privately-held healthcare company formed in 2005 with headquarters in Singapore and over 4000 employees across 13 countries. The document provides an overview of Invidia's vision, capabilities, partnerships, and geographic footprint, with a focus on their operations and capabilities in India. In India, Invidia has over 800 sales and marketing professionals covering 19 clients, including major brands like Pyridium, GSK Consumer Health, and Eli Lilly. The summary highlights Invidia's sales force management, regulatory expertise, and commercialization solutions in India.
Progressive is a leading recruitment consultancy specializing in healthcare, IT, pharmaceuticals, telecoms, and oil & gas. They provide recruitment services from 5 UK offices and locations in Europe and Asia Pacific. Progressive assigns each client an account manager dedicated to developing long-term relationships and understanding their needs. They use a database and network of consultants to efficiently source qualified candidates and place them in exclusive industry roles.
What we do: Pharmaceutical Consulting, Strategic Consulting, Pharmaceutical Strategic Consulting
Strategic Opportunity Assessment – Diagnostic process for continuously improving project managements performances.
Clinical site; KOL Evaluation in Asia – Development of clinical sites and evaluation of KOL treatment algorithms
Compliant manufacturing Site Proposal – Forecasting optimal asset allocation to achieve compliant manufacturing.
The new role of R&D and process for new products in pharmaceutical industry has been established
Productivity increase of Orion R&D within 6 years by :
-Classification of partners
-Partnering and outsourcing models in use
Need of reliable key metrics to value R&D investment and boost the future growth of the company
Gary Noy, Director of Integrated FM at Pfizer - Facilities management service...Global Business Events
This document summarizes Pfizer's facilities management outsourcing in Europe, the Middle East, and Africa (EMEA). It provides background on Pfizer's global operations and EMEA real estate footprint. In 2008-2009, Pfizer outsourced many FM services across EMEA to a single vendor, CBRE, through a competitive bidding process. Lessons learned from that initial outsourcing included allowing more time for change management and establishing clear contract governance. The current approach involves another desk-top outsourcing review starting in 2012 to select a new vendor for EMEA FM services beginning in 2014.
Este documento proporciona una introducción al concepto de outsourcing y sus características. Explica que el outsourcing implica delegar responsabilidades no esenciales a un proveedor externo para reducir costos y aumentar la eficiencia. También analiza las ventajas e inconvenientes del outsourcing, los tipos de contratos utilizados, y cómo este enfoque apoya la toma de decisiones gerenciales.
This document discusses outsourcing in the pharmaceutical industry. It defines outsourcing as transferring portions of work to outside suppliers in order to reduce costs. The main types of outsourcing in pharma include research and development, clinical trials, manufacturing, packaging, and sales/marketing. The key drivers of outsourcing are focusing on core strengths, reducing costs, and decreasing time to market. While outsourcing provides advantages like cost reductions, it also presents risks such as loss of managerial control and internal talent. Overall, outsourcing allows pharma companies to exploit new drug technologies while solving problems, though successful management of vendor relationships is critical.
Pfizer office of the future case study Mohamed Zaid
This document discusses Pfizer's Office of the Future (OOF) program. It provides an overview of Pfizer as a company and describes the OOF program, which involves outsourcing routine office work to companies in India. This allows Pfizer employees to focus on more strategic work instead of tasks like document creation and research. The program was implemented by establishing departments in outsourcing companies responsible for different tasks. It helps Pfizer improve efficiency by reducing costs and time spent on projects. However, the approach may not be suitable for all organization types and presents some risks if communication or systems fail.
Strategies and Opportunities of Outsourcing -Product Development and Manufact...daisyrmuzzio
This document discusses strategies and opportunities for outsourcing pharmaceutical product development and manufacturing services from Latin America. It notes that Latin America has the potential to become a key global outsourcing hub for these activities in the next 5-10 years due to benefits like industry growth, innovation, and capabilities to address local health needs. It highlights several Latin American countries' strengths in areas like clinical research capabilities, manufacturing infrastructure, and a growing biotech industry. It also discusses expectations for the region to close gaps in areas like regulatory environments and intellectual property protections.
The document is a business plan for BioCare Ltd's product called SlickStick. It contains details about the product, which is a rapid diagnostic test kit for malaria that combines a dipstick with a smartphone app for automated analysis. The business plan includes sections on the company description, product details, market analysis, financial projections, and risk analysis. It presents data showing the large market opportunity for lower-cost malaria diagnostics, especially in developing countries.
The document discusses the pharmaceutical industry and Pfizer's position as one of the largest companies in the sector, facing challenges from increasing competition, shorter patents, and the need to diversify beyond blockbuster drugs. It analyzes Pfizer's strengths in areas like research and development as well as opportunities for the company to move into new areas like medical devices, health insurance, and genetically modified foods.
The document discusses the history and evolution of outsourcing in various industries from the 1980s to present day. It covers the reasons companies outsource functions like production, purchasing, logistics, and services to reduce costs and risks. The document also outlines advantages and disadvantages of outsourcing as well as best practices for effective outsourcing.
The document summarizes research into marketing practices of pharmaceutical companies through case studies and interviews. Case studies of Claritin and Lipitor found differences in packaging and advertising between US/Canada and Europe. Interviews found that pharmaceutical representatives meet with doctors and pharmacists for 10-30 minutes to provide information, but independent assessment is still needed. While representatives have useful roles, direct-to-consumer drug advertising is seen as generally inappropriate.
Doug Kessler - Avoiding Crap - Succeeding at Content Marketing smm13Our Social Times
The document discusses strategies for creating "home run" content that performs significantly better than other content. It argues that home run content earns disproportionate attention, improves the performance of all other content, and can overcome obstacles like search engine inertia. It provides eight tips for producing home run content, such as swinging for the fences, studying other successful home runs, shamelessly stealing ideas from far-reaching sources, targeting psychographics, tapping into emotion, and addressing timely issues with empathy and confidence. The overall goal is to aim high and steal ideas freely in order to create content that can act as a home run.
Multi Format Content Strategy: Making Your Assets Go As Far As PossibleJames Carson
The document discusses elements of a content strategy, including creating different types of content assets for distribution across various platforms. It emphasizes starting with a user journey and having a central idea or theme. Different content formats are described as well as owned, earned and paid platforms. The overall message is that an effective content strategy focuses on the user and brings together various elements like formats, platforms and storytelling around a core idea.
How to Develop a PowerPoint Pitch Deck for Biotech Investor PresentationsCraig Shimasaki
A critical tool for all biotech entrepreneurs is an Investor Slide Deck or “Pitch” Deck. This example is provided to help those who want guidance on what topics and information are important for a biotech investor presentation. I have put together some basic information about what a biotech investor pitch deck should contain when presenting for the first time to a group of potential investors. Realize that this is not a template per se in which to simply fill in the blanks, but an ordered list of topics that are significant to most all biotechnology investors. For more information read the BioBlog at www.biosourceconsulting.com
Outsourcing es el proceso de contratar una empresa externa para realizar tareas específicas de una compañía. Esto puede reducir costos al evitar mantener un departamento interno. Algunas ventajas incluyen menores gastos, acceso a especialización externa y poder enfocarse en el negocio principal. Los contratos de outsourcing típicamente duran entre 3 a 10 años y cubren áreas como recursos humanos, TI, manufactura u otros procesos.
The document discusses outsourcing and provides examples of common business functions that are outsourced such as IT services, email hosting, database management, and network support. It notes that companies outsource to reduce costs, access new technologies, and focus on core competencies. The benefits and potential problems of outsourcing are also summarized.
El documento proporciona una introducción al concepto de outsourcing, explicando que es una estrategia en la que una empresa delega ciertas actividades a empresas especializadas externas para reducir costos y mejorar la eficiencia. Luego, describe algunos pioneros y ejemplos comunes de outsourcing, así como consideraciones clave para implementarlo de manera exitosa, como seleccionar el proveedor adecuado y gestionar efectivamente la transición.
Here are some key points to consider when managing a pharmaceutical product portfolio across the product life cycle:
- Balance pipeline, in-line, and mature products to ensure continuous revenue and profit streams as products move through stages of the PLC
- Allocate R&D, marketing resources appropriately based on products' stage in PLC
- Consider portfolio synergies - how products complement each other's markets, sales forces, etc.
- Manage patent expirations and generic competition for in-line products
- Continuously evaluate portfolio for gaps, underperformers, and divestment/acquisition opportunities
- Ensure pipeline has mix of early/late stage products and therapeutic areas for future growth
The goal is a balanced,
50 Stats You Need to Know About Content Marketing NewsCred
The 50 most important content marketing statistics that will help you prove the value of content and keep you accountable. To see a full list of the sources please click here: http://blog.newscred.com/article/4d5125444fcd2d72ebd17b282107d742/50-stats-you-need-to-know-about-content-marketing
Invida is a privately-held healthcare company formed in 2005 with headquarters in Singapore and over 4000 employees across 13 countries. The document provides an overview of Invidia's vision, capabilities, partnerships, and geographic footprint, with a focus on their operations and capabilities in India. In India, Invidia has over 800 sales and marketing professionals covering 19 clients, including major brands like Pyridium, GSK Consumer Health, and Eli Lilly. The summary highlights Invidia's sales force management, regulatory expertise, and commercialization solutions in India.
Progressive is a leading recruitment consultancy specializing in healthcare, IT, pharmaceuticals, telecoms, and oil & gas. They provide recruitment services from 5 UK offices and locations in Europe and Asia Pacific. Progressive assigns each client an account manager dedicated to developing long-term relationships and understanding their needs. They use a database and network of consultants to efficiently source qualified candidates and place them in exclusive industry roles.
Right time to Outsource your healthcare services to Avantha Business Solutionsavanthabsl
Ensure Maximum Profit margin at a minimal cost. Outsource to Avantha Business Solutions who have unmatched ability to grow its client’s businesses by innovating to improve client’s back-office processes.
The document describes pharmacovigilance and drug safety services provided by Ashfield Pharmacovigilance including signal detection, literature review, medical case management, global regulatory reporting, risk management, quality assurance, and IT services to support pharmacovigilance programs. Key services include signal detection and analysis, case processing, medical review, literature searching, global regulatory reporting, risk management plan development, and audit preparation. Ashfield has experience working with pharmaceutical companies to establish compliant and effective pharmacovigilance systems and processes.
Oliver James Associates is a specialist recruitment firm focused on placing talent in the financial services sector globally. They have offices across Europe, Asia, and Australia. Their unique search methodology involves extensively mapping markets to develop a thorough knowledge of the available talent pool. They focus on building long-term relationships with clients and candidates based on trust. This allows them to find candidates that other agencies cannot access, especially when demand for certain skills outstrips supply. They provide executive search, interim, and retained recruitment services tailored to clients' needs.
Medtech.Capabilities.Frost & Sullivan.2009Siddharth Singh
Frost & Sullivan is a growth consulting company. The "Healthcare Practices" focuses on identifying emerging opportunities in Medical Devices industry and offer various market strategies.
Sage is a leading supplier of business management software and services to more than 6 million customers worldwide. From small start-ups to larger organizations, we make it easier for companies to manage their business processes.
The document is a proposal from The ReThink Group to become a preferred supplier for 3663. It outlines ReThink's company overview including locations, strategy for growth, and differentiators such as experienced staff and proprietary technology. ReThink's proposed solution includes a dedicated team, effective communication, and maximizing sourcing opportunities. Terms, performance monitoring, and conclusions are also presented, with an invitation for questions.
This document provides information about assessment and recruitment solutions from two companies: Quo Vadis Consultants and Antal International Network. It outlines their services such as behavioral assessments, recruitment, and testing to help clients identify talent, remove costs, and enhance their business. Contact information is provided for the managing director and both companies' websites and addresses are listed.
The document discusses Covance's focus on integrating people, process, and clients. It highlights key areas like operational excellence, strategic partnering, thought leadership, client interactions, audits, and technical training. The goal is to provide signature client service, ensure quality, and support all business units and clients through high-quality training.
ISO 13485 Certification Everything You Need to Know.pdfOFFICE
ISO 13485 is a globally accepted standard designed to help medical device manufacturers maintain and continuously improve their quality management systems. It outlines the requirements for a comprehensive quality management system, covering every aspect from product development to manufacturing and post-market surveillance. This standard ensures that medical devices meet regulatory requirements and maintain the highest level of safety and efficacy.
The document summarizes Hydrogen's Life Sciences practice. It specializes in finding talent for clients in niche areas across the globe. It has specialist teams focused on areas like clinical research, medical affairs, and regulatory affairs. The practice develops long term relationships with candidates and clients. It has a global database and places candidates in over 70 countries. Case studies provide examples of successful partnerships recruiting for companies like Parexel, Medtronic, Actelion, and PPD.
Bilcare is an organization made up of motivated people, who believe in going that extra mile to spread excellence and joy. This is a global leader and an innovation-led packaging solutions provider that partners with the pharmaceutical industry to improve patient healthcare outcomes.
Genetic Technologies is an Australian company focused on developing and commercializing genetic risk assessment tests. The presentation provides an overview of the company's business, including its portfolio of current and upcoming genetic tests, markets and channels to market, and capabilities. Key points include:
- Genetic Technologies aims to offer the most comprehensive suite of genetic risk assessment tests on the market, covering up to 70% of disease risks.
- The company is prioritizing market entry strategies in key regions like Australia, the US, and Asia.
- Tests are marketed through consumer-initiated and medical business-to-business channels.
- An innovative pipeline of new tests for diseases like cancer, heart disease, and diabetes is being
This corporate presentation provides an overview of Adecco Group, including its vision, global reach, strategy, services and solutions, business segments, corporate social responsibility efforts, recent financial results, future perspectives, and global programmes. The presentation covers Adecco's vision of helping people better work and live, its network of over 32,000 employees in 60+ countries, strategic focus on key business lines and priorities, and range of staffing and talent development services. Financial results for Q2 2015 show revenue growth of 4% and adjusted EBITA margin of 4.9%. The presentation also outlines Adecco's approach to CSR and various global initiatives focused on youth employment, talent competitiveness, and career support for athletes.
Syed Asad Ali Naqvi is a results-oriented professional with over 17 years of experience in strategic management, marketing, business analysis, and research in the pharmaceutical, diagnostics, and healthcare industries. He has a background in business degrees and computer education. Naqvi has experience developing marketing strategies, budgets, and data analytical solutions. He is skilled in strategic planning, marketing management, and developing teams.
The document introduces Volt as a provider of recruitment services for life sciences and other industries. It summarizes that Volt has a long history of success in Europe since 1978, operates according to high quality standards, and offers flexible recruitment solutions ranging from individual hires to large managed service programs. It then provides more details on Volt's services for sectors like life sciences, IT, finance, sales and marketing, and describes Volt's candidate selection and screening process.
This document provides a comprehensive guide to BSI's certification schemes and services. It outlines 10 reasons to choose BSI, including their global network, over 100 years of experience in standards development, and commitment to continual improvement. The guide also details BSI's portfolios for performance, sustainability, risk, medical devices, Entropy software, key business sectors, and themes. Sections provide information on individual certification schemes including ISO 9001, ISO 14001, ISO 27001, and standards for various industries such as aerospace, automotive, oil and gas.
Orbis Clinical is a consulting firm focused on providing regulatory affairs, quality assurance, drug safety, and risk management expertise to biopharmaceutical clients. It has over 70 employees and has experienced strong revenue growth. Orbis Clinical delivers flexible, client-driven solutions through engaged consultants and a large virtual bench of additional experts.
Tech Observer is a global clinical research organization that has been operating since 2005. It has offices in 5 countries and provides medical affairs and clinical research services to support pharmaceutical and biotech clients through all phases of drug development. Some of its key services include medical writing, data management, biostatistics, and medical communication support. The presentation provides an overview of Tech Observer's capabilities and experience in various therapeutic areas.
Similar to Sec pharma presentation pietro bonanno (20)
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
The Steadfast and Reliable Bull: Taurus Zodiac Signmy Pandit
Explore the steadfast and reliable nature of the Taurus Zodiac Sign. Discover the personality traits, key dates, and horoscope insights that define the determined and practical Taurus, and learn how their grounded nature makes them the anchor of the zodiac.
L'indice de performance des ports à conteneurs de l'année 2023SPATPortToamasina
Une évaluation comparable de la performance basée sur le temps d'escale des navires
L'objectif de l'ICPP est d'identifier les domaines d'amélioration qui peuvent en fin de compte bénéficier à toutes les parties concernées, des compagnies maritimes aux gouvernements nationaux en passant par les consommateurs. Il est conçu pour servir de point de référence aux principaux acteurs de l'économie mondiale, notamment les autorités et les opérateurs portuaires, les gouvernements nationaux, les organisations supranationales, les agences de développement, les divers intérêts maritimes et d'autres acteurs publics et privés du commerce, de la logistique et des services de la chaîne d'approvisionnement.
Le développement de l'ICPP repose sur le temps total passé par les porte-conteneurs dans les ports, de la manière expliquée dans les sections suivantes du rapport, et comme dans les itérations précédentes de l'ICPP. Cette quatrième itération utilise des données pour l'année civile complète 2023. Elle poursuit le changement introduit l'année dernière en n'incluant que les ports qui ont eu un minimum de 24 escales valides au cours de la période de 12 mois de l'étude. Le nombre de ports inclus dans l'ICPP 2023 est de 405.
Comme dans les éditions précédentes de l'ICPP, la production du classement fait appel à deux approches méthodologiques différentes : une approche administrative, ou technique, une méthodologie pragmatique reflétant les connaissances et le jugement des experts ; et une approche statistique, utilisant l'analyse factorielle (AF), ou plus précisément la factorisation matricielle. L'utilisation de ces deux approches vise à garantir que le classement des performances des ports à conteneurs reflète le plus fidèlement possible les performances réelles des ports, tout en étant statistiquement robuste.
High-Quality IPTV Monthly Subscription for $15advik4387
Experience high-quality entertainment with our IPTV monthly subscription for just $15. Access a vast array of live TV channels, movies, and on-demand shows with crystal-clear streaming. Our reliable service ensures smooth, uninterrupted viewing at an unbeatable price. Perfect for those seeking premium content without breaking the bank. Start streaming today!
https://rb.gy/f409dk
Prescriptive analytics BA4206 Anna University PPTFreelance
Business analysis - Prescriptive analytics Introduction to Prescriptive analytics
Prescriptive Modeling
Non Linear Optimization
Demonstrating Business Performance Improvement
AI Transformation Playbook: Thinking AI-First for Your BusinessArijit Dutta
I dive into how businesses can stay competitive by integrating AI into their core processes. From identifying the right approach to building collaborative teams and recognizing common pitfalls, this guide has got you covered. AI transformation is a journey, and this playbook is here to help you navigate it successfully.
Cover Story - China's Investment Leader - Dr. Alyce SUmsthrill
In World Expo 2010 Shanghai – the most visited Expo in the World History
https://www.britannica.com/event/Expo-Shanghai-2010
China’s official organizer of the Expo, CCPIT (China Council for the Promotion of International Trade https://en.ccpit.org/) has chosen Dr. Alyce Su as the Cover Person with Cover Story, in the Expo’s official magazine distributed throughout the Expo, showcasing China’s New Generation of Leaders to the World.
Efficient PHP Development Solutions for Dynamic Web ApplicationsHarwinder Singh
Unlock the full potential of your web projects with our expert PHP development solutions. From robust backend systems to dynamic front-end interfaces, we deliver scalable, secure, and high-performance applications tailored to your needs. Trust our skilled team to transform your ideas into reality with custom PHP programming, ensuring seamless functionality and a superior user experience.
Presentation by Herman Kienhuis (Curiosity VC) on Investing in AI for ABS Alu...Herman Kienhuis
Presentation by Herman Kienhuis (Curiosity VC) on developments in AI, the venture capital investment landscape and Curiosity VC's approach to investing, at the alumni event of Amsterdam Business School (University of Amsterdam) on June 13, 2024 in Amsterdam.
Tired of chasing down expiring contracts and drowning in paperwork? Mastering contract management can significantly enhance your business efficiency and productivity. This guide unveils expert secrets to streamline your contract management process. Learn how to save time, minimize risk, and achieve effortless contract management.
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...Niswey
50 million companies worldwide leverage WhatsApp as a key marketing channel. You may have considered adding it to your marketing mix, or probably already driving impressive conversions with WhatsApp.
But wait. What happens when you fully integrate your WhatsApp campaigns with HubSpot?
That's exactly what we explored in this session.
We take a look at everything that you need to know in order to deploy effective WhatsApp marketing strategies, and integrate it with your buyer journey in HubSpot. From technical requirements to innovative campaign strategies, to advanced campaign reporting - we discuss all that and more, to leverage WhatsApp for maximum impact. Check out more details about the event here https://events.hubspot.com/events/details/hubspot-new-delhi-presents-unlocking-whatsapp-marketing-with-hubspot-integrating-messaging-into-your-marketing-strategy/
Discover the Beauty and Functionality of The Expert Remodeling Serviceobriengroupinc04
Unlock your kitchen's true potential with expert remodeling services from O'Brien Group Inc. Transform your space into a functional, modern, and luxurious haven with their experienced professionals. From layout reconfiguration to high-end upgrades, they deliver stunning results tailored to your style and needs. Visit obriengroupinc.com to elevate your kitchen's beauty and functionality today.
2. Contents
Introduction
Client List
Geographical Coverage
Sector Expertise
Recruitment Process & Candidate Resourcing
Account Management & Quality
Specific Services
Summary
This presentation will cover the following topics:
January 2015 Capability Presentation 2
4. SEC Pharma – Specialist Recruitment for Pharma
Search,
contingency and
contract / interim
models
Established in
2000
55 experienced
consultants,
speaking 21
languages
Leading edge
Technology for
candidate
sourcing
Active in over
20 European
countries
Specialist focus
on skill areas
January 2015 Capability Presentation 4
5. True Pan European Coverage
Placements made to date in:
January 2015 Capability Presentation 5
Austria
Belgium
Bulgaria
Cyprus
Czech Republic
Germany
Denmark
Finland
France
Gibraltar
Greece
Hungary
Ireland
Italy
Lithuania
Luxembourg
Latvia
Malta
Netherlands
Norway
Poland
Portugal
Romania
Russia
Serbia
Sweden
Slovakia
Slovenia
Switzerland
Spain
Ukraine
United Kingdom
6. Our Global Presence
SEC Recruitment provides talent acquisition services in over 20 countries.
As part of our clients’ requirements and business plans, we have taken the strategic decision of opening
offices across the globe to deliver even more efficient services to our clients.
We have also ensured compliance by securing licences where required, to meet both local and international
regulations, this includes the German AUG, Swiss and Singaporean Licences.
Switzerland
SEC Recruitment Schweiz AG
Germany
SEC Recruitment
United Kingdom
SEC Recruitment Ltd
Our global offices include:
Singapore
SEC Pharma Pte Ltd
January 2015 Capability Presentation 6
7. Capability Presentation
Our Global Reach
7
European Coverage
Austria, Belgium, Bulgaria, Cyprus, Czech
Republic, Denmark, France, Finland, Germany,
Gibraltar, Greece, Hungary, Ireland, Italy, Latvia,
Lithuania, Luxembourg, Malta, Netherlands,
Norway, Poland, Portugal, Romania, Russia,
Serbia, Slovakia, Slovenia, Spain, Sweden,
Switzerland, Ukraine & United Kingdom
Asia Pacific Region
Australia, China, Hong Kong,
India, Japan, Malaysia, Mongolia,
Philippines, Republic of China
(Taiwan), Singapore & Thailand
North America
Canada, Mexico &
United States
Africa
Congo, Mauritius, Nigeria,
Morocco & South Africa
Middle East
Israel, Jordan, Saudi
Arabia, Turkey &
United Arab Emirates
January 2015
8. SEC Pharma – more than 60 active clients
January 2015 Capability Presentation 8
We work with market leading companies including:
Parexel
Pfizer
PPD (PPO)
PRA International
Quintiles
Roche
Sandoz
Sanofi
Shire
Teva
GSK
ICON
inVentiv Health
Ipsen
Johnson & Johnson
Lilly
Meda
Merck Serono
MSD
Novartis
Actelion
Allergan
Amgen
AstraZeneca
Bausch + Lomb
Bayer
Boehringer Ingelheim
Celgene
Covance
Grunenthal
9. Skills Capability & Coverage – Pharma Specific
January 2015 Capability Presentation 9
Clinical
Operations
Clinical
Development
Data
Management
SAS
Programming
Statistics
Regulatory
Affairs
PVG
Medical
Affairs
Quality
Assurance
Sales &
Marketing
Medical
Comms.
HE&OR
Manufacturing
/ Engineering
Clinical IT
United Kingdom
France
Germany
Switzerland
Austria
Italy
Spain
Belgium
Netherlands
Ireland
Sweden
Denmark
Poland
Romania
Bulgaria
Czech Republic
Serbia
Croatia
Slovakia
Hungary
Very High High Medium No / Little Demand
Skills Capability & Coverage - Pharma Specific
10. Engineering & Manufacturing Skill Coverage
January 2015 Capability Presentation 10
Commissioning Qualification Validation Process Design
Electrical &
Instrumentation
Mechanical
Building
Services &
Utilities
Automation -
Control
Systems
Computer
Systems
Validation
Quality
Control
Quality
Assurance
Regulatory
Affairs
United Kingdom
Ireland
France
Germany
Switzerland
Austria
Italy
Spain
Belgium
Netherlands
Sweden
Denmark
Poland
Romania
Bulgaria
Czech Republic
Serbia
Croatia
Slovakia
Hungary
Very High High Medium No / Little Demand
Skills Capability & Coverage - Engineering & Manufacturing
11. Geographical IT Skill Coverage
January 2015 Capability Presentation 11
SAP / JDE Siebel AS / 400
Business
Intelligence
DWH / ETL
Senior
Appointments
PC
Development
IT
Infrastructure
Testing
Data
Management
OLAP /
Reporting
Direct /
Digital
Marketing
Data
Analysis /
Modelling
Market
Research
Customer
Insight
United Kingdom
France
Germany
Switzerland
Austria
Italy
Spain
Belgium
Netherlands
Luxembourg
Sweden
Denmark
Poland
Romania
Bulgaria
Czech Republic
Serbia
Croatia
Slovakia
Hungary
Very High High Medium No / Little Demand
Geographical IT Skill Coverage
12. Our Specialist Areas
January 2015 Capability Presentation 12
VP Medical Affairs
Head of Medical Affairs
Medical Affairs Director
Medical Affairs Manager
Medical Adviser
Medical Science Liaisons
Clinical Monitoring
Clinical Operations
Study Start-Up
Management
Study Management
Program Management
Line-Management & Senior
Appointments
VP Clinical Development
Head of Clinical
Development
Clinical Development
Director
Research Physician
Medical Monitor
Clinical Scientist
Clinical Outsourcing
Management
CRO & Vendors
Management
Business Area Manager
Business Development
Director
Contract & Proposal
Management
Pharmaceutical & CRO
Sales
Medical Affairs Clinical
Development
Clinical
Operations
BD, Contracts &
Proposals
Clinical
Outsourcing
13. Our Specialist Areas
Clinical Coders
Surgeons
Medical Doctors
Radiologists
Anaesthetists
Gynaecologists
Medics
Health Economics
Pharmacoeconomics
Outcomes Research
Market Access
Pricing & Re-Imbursement
Patient Reported Outcomes
Statistics
Modelling & Simulation
Pharmacokinetcs /
Pharmacodynamics
Epidemiology
Biostatistics
Statistical Programming
CDISC, SDTM & ADaM
SAS Programming &
Development
Data Management &
Electronic Data Capture
Clinical Programming
Brand Management
Product Management
Marketing
Medical Information
Medical Communications
Medical Writing
Account / Event
Management
Medical Education
Healthcare Biometrics CommercialMedical Comms.Health
Economics
13Capability PresentationJanuary 2015
14. Our Specialist Areas
January 2015 Capability Presentation 14
Data Entry
Case Processing
Signal Detection
Safety Profiling / Risk
Management
Safety Issue Management
Review & Implementation
of PV
Management of Safety
Data
Safety Team Management
CMC
Development
Life Cycle Management
Regulatory Liaison
Regulatory Strategy
Regulatory Operations
Regulatory Intelligence
Regulatory Compliance
Corporate GMP QA
Raw Materials
Quality Systems
Management
Microbiology
3rd Party QA Management
Biopharmaceuticals QA
Medical Devices QA
QA Auditors
Computer System
Validation
Upstream Processing
Downstream Processing
Technology Transfer
Analytical Chemistry
GMP Engineering
- Commissioning
- Validation
- Control & Automation
- Mechanical
- Electrical & Instrumentation
Processing Engineering
Project Management
Operations
Supply Chain
Maintenance
Drug Safety QA / QC
Regulatory
Affairs
Manufacturing &
Production
R&D
15. SEC Technology & Analytics
Business Intelligence
Data Warehousing
Credit Risk Analytics
Market Research
Marketing Analytics
Web Analytics
SPSS/SQL Analytics
Customer Relationship Management
SAP
SalesForce
Siebel
Oracle
JD Edwards
MS Dynamics
Java
IT Infrastructure
Software Development
Business Services
Project Management
Insurance, Financial
Services, Marketing and
Consultancy
ERP/CRM, IT Infrastructure
and Software Development
January 2015 Capability Presentation 15
16. Route to Market
Initial candidate shortlist
SEC interviews and filtering
Shortlist
Final selection
Research & preparation
Requirement understanding
Candidate search
Screening & filtering
Shortlist
Candidate profiles for client
Interview & selection
organisation
Post-interview discussion
Reference checking
Offer & acceptance management
Counter-offer response
2-10 week process
January 2015 16Capability Presentation
17. Account Management & Quality
Nominated
Account
Manager
Skill focussed
consultants
Contact &
communication
process agreed
Escalation
procedure if
required
Telephone and
face-to-face
meetings as
required
Reporting
monthly or
quarterly
Account Management process
agreed with each client
Internal Key Account Management
process
ISO 9000 certified
January 2015 Capability Presentation 17
18. Our Services
Permanent
Contingency
% of salary package
on start date
Retained
Staged payments
throughout process
Contract /
Freelance
Contractors /
Freelancers
Hourly charge
PAYE workers
Day or hourly rate
Candidate sourcing & selection
Weekly payrolling of candidate
Full in-country compliance:
German (AUG), Swiss and Singaporean Licence
Insurance & protection
Account Management
Payroll Process Outsourcing (PPO)
January 2015 Capability Presentation 18
19. SEC has been providing contingent workforce solutions since 1987.
During 2013 we implemented a streamlined partnership solution to:
Identify and/or manage your contingent workforce
Manage all contracts and administration
Provide legal, tax and contractual information
Manage payroll in-house
Implement processes that will meet your company’s goals
Consolidate suppliers
Enrol all workers on the SEC Contingent Care Program
Our Payroll Process Outsourcing model will enable you to:
Save Money: Reduce cost per hire on pre-selected/existing workforce
Mitigate Risks: Remove issues of deemed Employment - Right to work - Tax & Social Security obligations met
Reduce Administration, Cost & Time: Consolidated Invoicing - No contracts to administer - No back office
Avoid Complex Contract Legislation: Legal and financial obligations met = Compliance
Contingent Worker Care Program: Quality of Service - A happy worker is far more productive
Simple and Hassle Free: Simple - Efficient - Peace of mind
Critical Access to the European Market: Increase talent pool - Staying ahead of the competition for talent
19January 2015
Payroll Process Outsourcing (PPO)
Capability Presentation
20. Why SEC Pharma?
Old fashioned values are at the Heart of SEC:
Trust, Honesty, Integrity – Customer is King
Market Leaders
• One of the largest European pharmaceutical
recruitment specialists (70% of our business is in
Europe)
• Proven track record in sourcing candidates to an
International Client Base
• German AUG Licence and Swiss Licence Holders
• Singapore Office and Licence
• International set up based on Client requirement
• Award winning apprentice programme
Candidate Sourcing
• Extensive database of candidates – 15 years in
development
• Specialist Consultant by Vertical skill set
• Multilingual Consultant Base
• Large emphasis on ‘passive’ candidates
• Advanced technology identify additional
candidates in timely manner
• Ability to Video Interview candidates
Adding Value
• Testimonials are available from our Customers
• Access to Market Analysis e.g. Salary Survey
• Access to Central London Client Suite Free of
Charge
• Consultant to the Board (ex AstraZeneca) for
additional support to Customers
• Payroll Process Outsourcing (PPO)
Personal Approach
• Recruitment is personally handled by a dedicated,
experienced Consultant
• High touch personal service – Consultants really
believe in what they are doing
• Dedicated Account Management team
• Internal Training and Development
• Client/Consultant relationship built on trust
• Longevity of service across our Consultant base
offering continuity and expertise to our clients
January 2015 20Capability Presentation
21. Contact Us
UK, London
SEC Recruitment Ltd
Woolverstone House
61-62 Berners Street
London
W1T 3NJ
United Kingdom
+44 (0) 20 7255 6600
UK, Woking
SEC Recruitment Ltd
RDL House
1 Chertsey Road
Woking
Surrey
GU21 5AD
United Kingdom
+44 (0) 14 8388 8999
Switzerland
SEC Recruitment Schweiz AG
Löberenstrasse 47
6300 Zug
Switzerland
+41 (0)44 5803 717
Singapore
SEC Pharma Pte Ltd
371 Beach Road
#15-09 Keypoint
199597
Singapore
+65 92 979 345
Germany
SEC Recruitment
Rindermarkt 1
80333 München
Germany
+49 (0) 69 2222 2888
January 2015 Capability Presentation 21
Pietro Bonanno
Consultant
Email: pietro.bonanno@secpharma.com